Global High-Priority Regulatory Events — May 21, 2026

Global High Priority Market Events

By Gunpowder Editorial ·

50 high priority 50 total filings analysed

Executive Summary

Today's filing stream (May 21, 2026) reveals a market dominated by three major themes: a landmark consolidation in US REITs with the $69B AvalonBay-Equity Residential merger, a systemic liquidity crisis at Dalrada Technology Group, and a coordinated structural shift by 14 Puerto Rico closed-end funds toward open-end structures.

Period-over-period data shows decelerating growth in Indian conglomerates (ITC's revenue +10% YoY but profit only +1%) and extreme revenue contraction in micro-cap energy (Barnwell -29% YoY) and technology (Dalrada -44% YoY). Capital allocation is mixed—aggressive buybacks from Dhanuka Agritech (₹70Cr) and Zydus Lifesciences (₹1,100Cr) contrast with severe cash burn at Dalrada (cash down 52% to $82.6K). A notable pattern of leadership churn emerged with Glimpse Group losing its entire C-suite and Radian Group announcing a CEO transition, while insider activity remains sparse across the stream. The most actionable signals arise from the AvalonBay-EQR merger synergies ($175M gross), Obsidian Therapeutics' promising Phase 2 melanoma data (67% ORR), and the pivot-to-liquidity event across 14 Puerto Rico funds, which may unlock trapped NAV for investors.

Materiality, sentiment, and priority are scored by Gunpowder’s analysis pipeline. How we score filings →

Filing types in this digest: 8-K · 425 · 10-Q · S-1 · DEF 14A

Tracking the trend? Catch up on the prior Global High-Priority Regulatory Events digest from May 20, 2026.

Investment Signals (11)

  • All-stock merger of equals creating $52B market cap REIT with $175M gross synergies; AvalonBay shareholders receive 2.793 EQR shares per share; combined entity to yield $2.81/share dividend.

  • Obsidian Therapeutics / OBX-115 (BULLISH)

    Phase 2 data in advanced melanoma showed 67% objective response rate (2 complete responses) with no dose-limiting toxicities; pursuing accelerated approval pathway with registration cohort mid-2026.

  • PHX Minerals Inc. (BULLISH)

    Net income swung to $4.38M from -$0.18M YoY (profit turnaround), driven by 47% revenue surge and 86.5% natural gas revenue growth; $30.25M undrawn credit facility provides flexibility.

  • New CEO Michael Weinbach appointed with aggressive $15M+ total comp package and 500K-share inducement plan; successor CEO signal often precedes strategic shift. [NEUTRAL/BULLISH]

  • ₹1,100Cr buyback at ₹1,150/share through tender route—5.2% of outstanding; buybacks at premium to market indicate strong management confidence in valuation.

  • Buyback of ₹70Cr at ₹1,400/share (4.20% of equity); promoters participating signals insider alignment and belief shares are undervalued.

  • New SPAC priced at $10.00 raising $75M, targeting healthcare; RA Capital sponsorship provides high-quality deal sourcing pipeline.

  • Net loss narrowed 4.7% to -$1.15M despite 29% revenue collapse; cost-cutting (opex -19%) and $338K equity income partially offset oil/gas sales decline.

  • Change-of-control open offer at ₹5/share (face value); acquirers taking 52% via preferential allotment and warrants; arbitrage opportunity if book value materially exceeds offer. [NEUTRAL/BULLISH]

  • Puerto Rico Closed-End Funds (14 funds) (BULLISH)

    Collective strategic review to merge into open-end structure providing daily NAV liquidity; could trigger significant NAV convergence trade for funds trading at structural discounts.

  • UK asset sale (Park Holidays) for £768M ($1.03B) all-cash; ~95% of NOI to be North American post-close—simplification story with deleveraging catalyst.

Risk Flags (10)

  • Dalrada Technology Group [HIGH RISK]

    Cash down 52% to $82.6K, stockholders' deficit tripled to -$20.9M, current liabilities ($29.9M) exceed current assets ($8.0M) by 3.7x—acute going-concern risk with zero operating runway.

  • Glimpse Group (VRAR) [HIGH RISK]

    Complete leadership vacuum—CEO, CFO, COO, Chairperson, and Board member resigned in single event; no permanent replacements named; management continuity risk extreme.

  • Arshiya Limited [HIGH RISK]

    Filed Q2 FY2024 results nearly 2 years late (May 2026 for June 2024 quarter); company in CIRP (insolvency)—severe reporting non-compliance indicates operational failure.

  • ₹5.53Cr customs duty demand plus equal penalty for HSN misclassification; company plans appeal but risks escalation if customs law interpretation goes against precedent.

  • ITC Limited [MEDIUM RISK]

    Profit growth only +1% despite +10% revenue growth—margin compression of ~90 bps; Paperboards segment profit declined -12.6% YoY; GST compensation cess expiry hitting cigarette excise structure.

  • Voluntarily paid ₹5.16L penalty for non-compliance with board composition rules (less than 6 directors for 84 days) and lack of qualified company secretary (17 days)—governance red flag. [LOW/MEDIUM RISK]

  • BankUnited [MEDIUM RISK]

    Equity plan approval received only 60.2% support with 39.8% against—unusually high dissent for share issuance authorization; signals institutional investor discontent.

  • Veritone, Inc. [MEDIUM RISK]

    Filed $50M ATM offering with 3.0% agent compensation; dilutive capital raise without disclosed use of proceeds or operational update suggests cash burn concerns.

  • Standalone total comprehensive income declined -4.8% YoY despite 5.3% revenue growth; margin deterioration suggests competitive pricing pressure or input cost inflation. [LOW/MEDIUM RISK]

  • HCW Biologics [MEDIUM RISK]

    Only $4.0M private placement at $1.405/unit with warrant coverage at $1.28—small raise for clinical-stage biotech pursuing multiple trials; cash runway limited.

Opportunities (9)

  • Spread between AVB conversion ratio (2.793 EQR shares) and current market prices; $52B market cap ensures liquidity; expected close H2 2026.

  • Obsidian Therapeutics (OPPORTUNITY)

    Phase 2 67% ORR in advanced melanoma with clean safety profile positions OBX-115 as potential best-in-class cellular therapy; accelerated approval pathway de-risks development timeline.

  • PHX Minerals (OPPORTUNITY)

    Natural gas revenue surged 86.5% YoY vs oil +5.5%; pure-play natural gas exposure with $100M credit facility ($30.25M undrawn); net earnings turned positive—trading at discount to upstream peers.

  • Puerto Rico Closed-End Funds NAV Trade (OPPORTUNITY)

    14 funds evaluating open-end conversion; current closed-end structure likely implies discount to NAV; conversion catalyst could narrow or eliminate discount—size aggregate liquidity event.

  • Sun Communities UK Sale (OPPORTUNITY)

    £768M ($1.03B) all-cash divestiture at 9.5x EBITDA (est.); proceeds to strengthen balance sheet and focus on 95% North American MH/RV portfolio; REIT simplification premium potential.

  • Zydus Lifesciences Buyback (OPPORTUNITY)

    ₹1,100Cr tender at ₹1,150/share with promoters likely participating; 5.2% of equity being retired—earnings accretion + signal of undervaluation for pharma company with strong pipeline.

  • Somany Ceramics Amalgamation (OPPORTUNITY)

    NCLT-approved merger of 3 wholly owned subsidiaries (Somany Bathware, Excel Vitrified, SR Continental) with no share issuance—cost synergies and simplification; shareholder meetings June 13, 2026.

  • Radian Group CEO Transition (OPPORTUNITY)

    Michael Weinbach joining from outside with fresh strategic mandate; $8M in sign-on PSUs/RSUs aligns interests; 500K-share inducement plan—insider accumulation potential before August 13 start.

  • ITC Dividend Yield (OPPORTUNITY)

    Final dividend ₹8 + interim ₹6.50 = ₹14.50 total; record date May 27, 2026 consistent 7-year dividend growth; 4.2% yield at current prices with cigarette pricing power intact.

Sector Themes (6)

  • REIT Mega-Consolidation (SECTOR THEME)

    AvalonBay-EQR $69B merger creates largest US apartment REIT with 180K+ units and $175M synergy target; follows Sun Communities' UK exit—REITs optimizing scale and geographic focus simultaneously.

  • Indian Corporate Buyback Wave (SECTOR THEME)

    Three buybacks in a single day—Dhanuka Agritech (₹70Cr), Onward Technologies (undisclosed), Zydus Lifesciences (₹1,100Cr); aggregate ~₹1,270Cr being returned to shareholders; suggests management teams see value amid market weakness.

  • Puerto Rico Closed-End Fund Restructuring (SECTOR THEME)

    14 separate funds simultaneously evaluating open-end conversion; unprecedented coordination suggests regulatory or tax catalyst; creates potential for sector-wide NAV realization event.

  • Micro-Cap Liquidity Crisis (SECTOR THEME)

    Dalrada cash down 52% to $82.6K, Barnwell cash burn up 184% to $2.42M in H1, HCW Biologics only raised $4M—three micro-caps showing acute capital constraints despite differing sectors.

  • Indian Conglomerate Margin Squeeze (SECTOR THEME)

    ITC (+10% revenue vs +1% profit) and Fine Organic Industries (+5.3% revenue vs -4.8% total comprehensive income) both show significant operating deleverage; input costs or competitive pressure eroding margins.

  • SPAC Activity Resurgence (SECTOR THEME)

    Research Alliance Corp III (RACC) $75M healthcare SPAC priced at $10; Parataxis Holdings going public via SilverBox Corp IV (SBXD) SPAC merger—two SPAC-related filings signal renewed issuance appetite.

Watch List (8)

  • AvalonBay Communities (AVB) / Equity Residential (EQR)
    👁

    Merger synergies realization and shareholder vote timeline; watch for regulatory clearance updates and any competing bids for apartment portfolios. [H2 2026]

  • Dalrada Technology Group (IMMINENT)
    👁

    Cash runway of approximately 2 months at current burn rate; watch for emergency financing, reverse split, or bankruptcy filing; May 21 10-Q disclosed worsening liquidity.

  • Puerto Rico Closed-End Funds (14 funds)
    👁

    SEC registration on Form N-14 and shareholder vote schedule; watch for arbitrageurs accumulating to influence conversion vote; strategic update May 20. [MID-2026]

  • Glimpse Group (VRAR)
    👁

    CEO transition to Tyler Gates expected June 2026; watch for director appointments and CFO hiring; current leadership vacuum creates binary event risk. [JUNE 2026]

  • Record date May 27, 2026 for ₹8 dividend; AGM July 23, 2026; watch for excise duty impact on cigarette volumes in Q1 FY27 results. [May-July 2026]

  • Obsidian Therapeutics
    👁

    Registration-enabling cohort for OBX-115 starting mid-2026; watch for Phase 2 data update at medical conferences and FDA meeting minutes for accelerated approval path. [MID-2026]

  • CEO-Elect Weinbach assumes role June 1, official CEO August 13; watch for strategic pivot announcement, capital return policy changes, or M&A. [June-August 2026]

  • Shareholder meetings June 13, 2026 for amalgamation approval; watch for NCLT final order and post-merger cost synergy disclosure. [June 13, 2026]

Filing Analyses (50)
Dhanuka Agritech Limited Buyback positive materiality 8/10

21-05-2026

Dhanuka Agritech Limited announced a buyback of up to 500,000 equity shares at ₹1,400 per share for an aggregate consideration of up to ₹70.00 Crore, representing 4.20% of the company's paid-up equity share capital and free reserves. The buyback will be conducted through the tender offer route on a proportionate basis, with a record date of May 29, 2026. Promoters and promoter group entities have expressed their intention to participate in the buyback.

  • · The buyback is being managed by Sundae Capital Advisors Private Limited (SEBI Regn. No.: INM000012494).
  • · The public announcement was published on May 21, 2026 in Business Standard (English and Hindi editions).
  • · The record date for determining eligible shareholders is May 29, 2026.
  • · Promoters and promoter group collectively hold 69.71% of the equity share capital as of the public announcement date.
  • · The buyback is within the limit of 4.20% of the aggregate of paid-up equity share capital and free reserves as per audited financials as on March 31, 2026.
  • · The company confirms no defaults in repayment of deposits, debentures, preference shares, or term loans.
  • · The board has passed a declaration of solvency.
ITC Limited Board Meeting mixed materiality 8/10

21-05-2026

ITC Limited reported standalone revenue from operations of ₹81,640.11 Cr for FY26, up 10.0% YoY from ₹74,238.13 Cr, while profit from continuing operations rose marginally 1.0% to ₹20,286.42 Cr from ₹20,093.29 Cr. However, the FMCG-Cigarettes segment revenue surged 13.7% to ₹37,099.65 Cr, but the Agri Business segment revenue declined 15.7% to ₹3,074.86 Cr in Q4 FY26 vs Q4 FY25, and Paperboards, Paper & Packaging segment profit fell 12.6% for the full year. The Board recommended a final dividend of ₹8.00 per share, bringing total dividend to ₹14.50 per share.

  • · Exceptional items of ₹183.87 Cr include ₹271.95 Cr one-time past service cost due to New Labour Codes and ₹88.08 Cr insurance claim settlement.
  • · Amalgamation of Sresta Natural Bioproducts and Wimco with ITC effective from appointed dates in FY26; Sresta's results included from 13 June 2025.
  • · GST Compensation Cess expiry led to increased excise duty on cigarettes from 1 Feb 2026, impacting comparability of revenue and excise duty figures.
  • · Board recommended re-appointment of Hemant Bhargava as Independent Director for five years from 20 Dec 2026.
  • · 115th Annual General Meeting scheduled for 23 July 2026; record date for final dividend is 27 May 2026.
ITC Limited Result mixed materiality 8/10

21-05-2026

ITC Limited reported standalone revenue from operations of ₹81640.11 Crore for the twelve months ended March 31, 2026, up 10.0% from ₹74238.13 Crore in the prior year, driven by strong growth in the FMCG-Cigarettes segment (+13.7% to ₹37099.65 Crore). However, profit from continuing operations grew only 1.0% to ₹20286.42 Crore, and the Paperboards, Paper & Packaging segment saw a 12.6% decline in segment results to ₹796.71 Crore. The Board recommended a final dividend of ₹8.00 per share, bringing the total dividend to ₹14.50 per share.

  • · The Board recommended re-appointment of Mr. Hemant Bhargava as an Independent Director for five years from December 20, 2026.
  • · The amalgamation of wholly owned subsidiaries Sresta Natural Bioproducts Private Limited and Wimco Limited with ITC was approved by NCLT and effective from appointed dates in FY26.
  • · Exceptional items for FY26 include a one-time past service cost of ₹271.95 Crore due to new labour codes and an insurance claim receipt of ₹88.08 Crore.
  • · The total dividend for FY26 is ₹14.50 per share (interim ₹6.50 + final ₹8.00), compared to ₹14.35 per share in FY25.
  • · The 115th Annual General Meeting is scheduled for July 23, 2026.
  • · Record date for final dividend is May 27, 2026; payment between July 24-29, 2026.
Arshiya Limited Insolvency negative materiality 7/10

21-05-2026

Arshiya Limited, currently under Corporate Insolvency Resolution Process (CIRP), has published newspaper advertisements for its standalone unaudited financial results for the quarter ended June 30, 2024, which were filed almost two years late (on May 21, 2026). The filing primarily confirms that the company is undergoing insolvency resolution, and the financial results themselves are for a period that is now historically dated, making current financial health assessment difficult.

  • · The filing is for the quarter ended June 30, 2024, but was published on May 21, 2026 — a delay of nearly two years, indicating severe reporting non-compliance.
  • · The company is under Corporate Insolvency Resolution Process (CIRP), with Mr. Pankaj Mahajan serving as the Resolution Professional.
  • · The results were published in The Financial Express (English, all India edition) and Navakal (Marathi, Mumbai edition).
  • · The company's registered office is at Arshiya FTWZ, Sai Village, Panvel, Raigad, Maharashtra.
  • · No specific financial figures (revenue, profit/loss, assets, etc.) are provided in the filing text — the filing only references the fact of publication of newspaper advertisements.
  • · The Resolution Professional's IBBI registration number is IBBI/IPA-001/IP-P00836/2017-2018/11420, with validity up to December 31, 2026.
ERP OPERATING LTD PARTNERSHIP 8-K mixed materiality 9/10

21-05-2026

AvalonBay Communities (AVB) and Equity Residential (EQR) announced a definitive all-stock merger of equals, creating a combined company with a pro forma equity market capitalization of approximately $52 billion and enterprise value of approximately $69 billion, encompassing over 180,000 rental apartments. The transaction is expected to generate $175 million in gross synergies and $125 million in net synergies, with an initial annualized dividend of $2.81 per share. However, the merger is subject to shareholder approvals and other customary closing conditions, with completion expected in the second half of 2026, and involves the retirement of EQR's CEO Mark J. Parrell, introducing leadership transition risk.

  • · AvalonBay shareholders will receive 2.793 shares of Equity Residential common stock for each AvalonBay share.
  • · The combined company will have dual headquarters in Arlington, VA and Chicago, IL and operate under a new name at closing.
  • · The transaction is expected to qualify as a tax-free reorganization for U.S. federal income tax purposes.
  • · Both companies intend to maintain regular quarterly dividend payments through completion of the transaction.
  • · The combined company currently includes affordable housing in 30% of its communities, representing about 7,200 affordable apartment units.
  • · AvalonBay owned or held 319 communities with 98,271 apartment homes as of March 31, 2026.
  • · Equity Residential owns 312 properties with 85,211 apartment units.
  • · The full management team will be announced prior to closing and is expected to include substantial representation from both companies.
AVALONBAY COMMUNITIES INC 8-K mixed materiality 9/10

21-05-2026

AvalonBay Communities and Equity Residential announced a definitive all-stock merger of equals, creating a combined company with a pro forma equity market capitalization of approximately $52 billion and enterprise value of $69 billion, encompassing over 180,000 rental apartments. The transaction is expected to generate $175 million in gross synergies and $125 million in net synergies, with AvalonBay shareholders receiving 2.793 shares of Equity Residential common stock per share, resulting in 51.2% ownership for AvalonBay and 48.8% for Equity Residential. However, the merger faces execution risks including shareholder approval requirements and integration challenges, and the combined company's initial annualized dividend of $2.81 per share is higher than AvalonBay's current yield but equivalent to Equity Residential's existing dividend.

  • · Transaction expected to close in second half of 2026, subject to shareholder approvals and customary conditions.
  • · Merger qualifies as a tax-free reorganization for U.S. federal income tax purposes.
  • · Combined company will have dual headquarters in Arlington, VA and Chicago, IL, operating under a new name to be announced at closing.
  • · Board of Trustees will consist of 7 existing trustees from Equity Residential and 7 existing directors from AvalonBay, with Steve Sterrett as Chairman.
  • · Benjamin Schall will serve as President, CEO, and Trustee of the combined company; Mark J. Parrell will retire at closing.
  • · Combined company has A3/A- credit ratings from Moody's and S&P respectively.
  • · 30% of combined communities include affordable or mixed-income housing, representing about 7,200 affordable units.
  • · Both companies intend to maintain regular quarterly dividends until transaction close.
Unknown Monetary Policy materiality 6/10

21-05-2026

Research Alliance Corp III 8-K positive materiality 8/10

21-05-2026

Research Alliance Corporation III, a SPAC sponsored by an affiliate of RA Capital Management, L.P., priced its initial public offering of 7,500,000 Class A ordinary shares at $10.00 per share, raising $75 million. The shares will trade on the Nasdaq Capital Market under the ticker symbol "RACC" starting May 20, 2026, with the offering expected to close on May 21, 2026. The company intends to focus its search for a business combination target in the healthcare or healthcare-related industries.

  • · The offering is being made only by means of a prospectus, copies of which can be obtained from Leerink Partners LLC.
  • · The registration statement was declared effective by the SEC on May 19, 2026.
  • · The company is a blank check company incorporated for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination.
  • · The company may pursue an initial business combination in any business, industry, sector or geographical location, but intends to focus on healthcare or healthcare-related industries.
  • · The financing included participation from multiple institutional investors including ADAR1 Capital, Affinity Asset Advisors, Balyasny Asset Management, Braidwell LP, BVF Partners, Cormorant Asset Management, Foresite Capital, Janus Henderson Investors, Perceptive Advisors, SilverArc Capital, Spruce Street Capital, TCGX, Trails Edge Capital Partners, and Venrock Healthcare Capital Partners.
Glimpse Group, Inc. 8-K negative materiality 9/10

21-05-2026

On May 15, 2026, The Glimpse Group, Inc. (VRAR) announced the resignations of three directors and officers: Jeff Enslin (Board member), Maydan Rothblum (CFO, COO, Secretary, Treasurer, and Board member), and Lyron Bentovim (Chairperson, President, CEO, and Board member). All resignations were stated as not due to any disagreement with the Company. The Company expects to appoint a new director, a new CFO, and to transition Tyler Gates (current GM of Brightline Interactive) to CEO during June 2026, though no assurances are given. The departures represent a near-complete turnover of top leadership, creating significant uncertainty about management continuity and strategic direction.

  • · Jeff Enslin's term was set to expire at the 2028 annual meeting.
  • · Maydan Rothblum is expected to remain as an advisor to the Board for legacy matters, public company management, strategy, capital markets, and finance team/audit transition.
  • · Lyron Bentovim's resignation is effective June 15, 2026, while the others are effective immediately (May 15, 2026).
  • · The Company is an emerging growth company and has not elected to use the extended transition period for new financial accounting standards.
Parataxis Holdings Inc. 425 mixed materiality 8/10

21-05-2026

Parataxis Holdings Inc. is going public via a SPAC merger with SilverBox Corp IV (NYSE: SBXD), as disclosed in a Rule 425 filing. Concurrently, Parataxis Capital launched the Parataxis Systematic Alpha Fund, a fully systematic hedge fund targeting intraday volatility in Bitcoin and Ethereum, with a target return of 25%-30% and ~15% annualized volatility. However, the broader digital-asset hedge fund index has been under pressure, dropping 11.6% in 2025 and remaining down 7% year-to-date through April 2026, indicating a challenging market backdrop.

  • · Parataxis Systematic Alpha Fund launched on May 1, 2026, with ~$5M in assets.
  • · The fund offers dollar-denominated and crypto-denominated share classes (Bitcoin, Ethereum, XRP).
  • · Parataxis acquired digital-asset hedge fund manager Strix Leviathan in February 2025.
  • · Parataxis Holdings created a Bitcoin-based digital-asset treasury via acquisition of KOSDAQ-listed Bridge Biotherapeutics in June 2025.
  • · Parataxis Holdings announced a near-majority stake in Sinsiway in December 2025 for an Ethereum-focused treasury (Parataxis ETH).
  • · The firm is seeking a third publicly traded shell company for an undisclosed digital asset.
  • · SilverBox Corp IV completed its $200M IPO in August 2024 and trades under ticker 'SBXD' on NYSE.
HCW Biologics Inc. 8-K neutral materiality 7/10

21-05-2026

HCW Biologics Inc. announced the pricing of a $4.0 million private placement of 2,846,975 units at $1.405 per unit to healthcare investors, with E.F. Hutton & Co. as sole placement agent. The company intends to use net proceeds to continue clinical trials for HCW9302, advance IND-enabling studies for its T-Cell Engager HCW11-018b and second-generation immune checkpoint inhibitor HCW11-040, and for general corporate purposes and debt/settlement payments. The offering closed on May 21, 2026, and a registration rights agreement was entered into for resale of shares.

  • · The warrants have an exercise price of $1.28 per share, are exercisable immediately, and expire on the five and one-half year anniversary of issuance.
  • · Shares of common stock (or pre-funded warrants) and warrants are immediately separable and issued separately.
  • · The company entered into a registration rights agreement on May 21, 2026, requiring an initial Form S-1 filing within 60 days of closing.
  • · The number of shares issuable to any investor is capped at 4.99% of outstanding common stock after the offering.
  • · The company has previously entered into two licensing agreements for exclusive worldwide rights to some proprietary molecules.
BankUnited, Inc. 8-K mixed materiality 6/10

21-05-2026

BankUnited, Inc. held its 2026 Annual Meeting on May 21, 2026, where shareholders approved the Amended and Restated 2023 Omnibus Equity Incentive Plan, increasing the share reserve by 1.5 million shares to a total of 2,301,549 shares and extending the plan termination date to May 21, 2036. All nine director nominees were elected, and the appointment of Deloitte & Touche LLP as independent auditor for 2026 was ratified. However, the advisory vote on executive compensation (Say-on-Pay) received only 89.5% support, and the equity plan approval was notably close, with 60.2% for and 39.8% against, indicating significant shareholder dissent.

  • · The Amended Plan extends the termination date from May 16, 2033 to May 21, 2036.
  • · The equity plan approval received 36,175,265 For votes, 23,906,092 Against, and 993,760 Abstain, with 6,891,801 broker non-votes.
  • · The Say-on-Pay proposal received 54,673,360 For, 6,236,321 Against, and 165,436 Abstain, with 6,891,801 broker non-votes.
  • · Auditor ratification was overwhelmingly approved with 67,952,223 For, 7,163 Against, and 7,532 Abstain.
  • · All director nominees were elected with For votes ranging from 59,527,530 (Sanjiv Sobti) to 60,953,296 (John N. DiGiacomo).
RADIAN GROUP INC 8-K neutral materiality 7/10

21-05-2026

Radian Group Inc. announced the appointment of Michael Weinbach as CEO-Elect effective June 1, 2026, and as CEO and Board member effective August 13, 2026, succeeding Richard G. Thornberry who will retire as CEO and Board member on August 12, 2026. Weinbach will receive a total compensation package including a $1M base salary, a 2026 STI target of $1,166,666, a $6M LTI award, and sign-on equity awards totaling up to $8M in PSUs and RSUs. The company also adopted a new 2026 Inducement Grant Equity Plan reserving 500,000 shares for equity grants to new hires.

  • · Weinbach's employment agreement has an initial term through December 31, 2029, with automatic one-year renewals unless 180-day notice is given.
  • · Weinbach will receive severance of 2x base salary plus 2x target STI award if terminated without cause or for good reason, plus prorated STI and 18 months of medical coverage reimbursement.
  • · The CEO Employment Agreement includes a restrictive covenant with an 18-month non-compete period post-termination.
  • · Weinbach must purchase a matching number of shares of Radian common stock to retain the Match Sign-On RSUs.
  • · The Inducement Plan was adopted without stockholder approval under NYSE Rule 303A.08.
  • · Weinbach holds an MBA from Harvard Business School and a BS in Economics from The Wharton School.
Veritone, Inc. 8-K neutral materiality 7/10

21-05-2026

Veritone, Inc. entered into a Sales Agreement with UBS Securities LLC, Needham & Company, LLC, and Craig-Hallum Capital Group LLC to offer and sell up to $50.0 million of its common stock from time to time in at-the-market offerings. The Sales Agents will receive up to 3.0% of gross sales price as compensation, and the company is not obligated to sell any shares. The filing does not include any period-over-period financial comparisons, so no balanced performance analysis is possible.

  • · The Sales Agreement was entered into on May 21, 2026.
  • · The offering is made under an existing effective registration statement on Form S-3 (File No. 333-280148) effective June 21, 2024.
  • · Sales may be made directly on The Nasdaq Global Market or any other trading market for the company's common stock.
  • · The Sales Agents will use commercially reasonable efforts to sell shares based on company instructions.
  • · The company will reimburse the Sales Agents for certain expenses and provide indemnification against certain liabilities.
  • · The offering may terminate upon election of Sales Agents on adverse events, ten days' advance notice from either party, or mutual agreement.
  • · No period-over-period financial data is included in this filing.
Galera Therapeutics, Inc. 425 positive materiality 8/10

21-05-2026

Obsidian Therapeutics announced positive Phase 2 clinical data for OBX-115 in advanced melanoma, showing a 67% objective response rate (ORR) at the recommended Phase 2 dose (RP2D), including 2 complete responses. The therapy demonstrated a favorable safety profile with no dose-limiting toxicities, ICANS, ICU transfers, or treatment-related mortality. However, the data are from a small single-arm study (n=15) with a median follow-up of only 4.3 months, and the company plans to pursue a single-arm accelerated approval pathway with a registration-enabling cohort starting mid-2026.

  • · Median follow-up was 4.3 months as of the January 22, 2026 data cutoff.
  • · No dose-limiting toxicities (DLT), treatment-related mortality (TRM), ICANS, or ICU transfers were observed.
  • · Majority of treatment-emergent adverse effects (TEAEs) occurring in ≥20% of patients were Grade 2 or less.
  • · Obsidian plans to begin treating patients in the registration-enabling cohort in mid-2026.
  • · NSCLC Phase 1 data from the Agni-01 trial are expected in the first half of 2027.
  • · The filing relates to the proposed merger between Galera and Obsidian under an Agreement and Plan of Merger dated April 14, 2026.
Ashoka Refineries Ltd Regulatory Action materiality 6/10

21-05-2026

LIC Housing Finance Limited Company Update neutral materiality 2/10

21-05-2026

LIC Housing Finance Ltd. has informed the stock exchanges that the transcript of its Q4 FY2025-26 earnings conference call, held on May 14, 2026, has been uploaded to the company's website. This disclosure is made in compliance with SEBI (LODR) regulations.

  • · The conference call was held on Thursday, 14th May, 2026 at 11:30 AM IST.
  • · The call discussed the Audited financial results for the quarter and year ended 31st March, 2026.
  • · The transcript is available at https://www.lichousing.com/investors/concall-transcript.
Somany Ceramics Limited Insolvency neutral materiality 5/10

21-05-2026

Somany Ceramics Limited received a corrigendum order from the NCLT Kolkata Bench on May 20, 2026, correcting typographical errors in the earlier order dated April 9, 2026, by replacing 'Scheme of Arrangement' with 'Scheme of Amalgamation' for the amalgamation of its wholly owned subsidiaries Somany Bathware Limited, Somany Excel Vitrified Private Limited, and SR Continental Limited into itself. The NCLT has dispensed with meetings of equity shareholders and creditors of the transferor companies (all wholly owned) and directed meetings of equity shareholders and unsecured creditors of Somany Ceramics (the transferee) to be held on June 13, 2026. The scheme is proposed with an appointed date of April 1, 2025, and no shares or securities will be issued under the scheme as the entire share capital of the transferor companies is held by the transferee.

  • · The corrigendum order was dated April 24, 2026, and received by the company on May 20, 2026.
  • · The NCLT order dispensed with meetings of equity shareholders and all creditors of the three transferor companies (all wholly owned subsidiaries).
  • · Meetings of equity shareholders and unsecured creditors of Somany Ceramics Limited (transferee) are scheduled for June 13, 2026, at 11:30 AM and 12:30 PM respectively.
  • · The appointed date for the amalgamation is April 1, 2025.
  • · No shares or securities will be issued under the scheme; the entire share capital of the transferor companies will be cancelled.
  • · The scheme is not within the purview of the Competition Act, 2002.
  • · The statutory auditors have confirmed that the accounting treatment in the scheme conforms to Accounting Standards under Section 133 of the Companies Act, 2013.
Onward Technologies Limited Buyback neutral materiality 5/10

21-05-2026

Onward Technologies Limited has filed a Letter of Offer dated May 19, 2026 with SEBI and stock exchanges for a buyback of its fully paid-up equity shares of face value ₹10 each. The Letter of Offer and Tender Form were dispatched on May 20, 2026 to eligible shareholders as of the record date of May 18, 2026. A dispatch advertisement was published on May 21, 2026. The buyback is being managed by Centrum Broking Limited.

  • · Record date for eligible shareholders: Monday, May 18, 2026
  • · Letter of Offer filed with SEBI and stock exchanges on May 20, 2026
  • · Dispatch advertisement published on May 21, 2026 in newspapers where the Public Announcement was published
  • · Buyback is under the Securities and Exchange Board of India (Buy-back of Securities) Regulations, 2018
Noble Polymers Ltd Open Offer neutral materiality 8/10

21-05-2026

The filing details a mandatory open offer under SEBI (SAST) Regulations by Acquirers Mr. Mahesh Alabhai Odedra and Mr. Hiren Rambhai Odedra to acquire up to 22,76,406 equity shares (26% of emerging voting capital) of Noble Polymers Ltd at ₹5 per share, for a maximum consideration of ₹1,13,82,030 (₹1.138 Cr). The offer follows a preferential allotment of 22,76,400 equity shares and 60,00,000 convertible warrants (to Acquirer-1) approved by the Board on May 14, 2026. Post-acquisition, the Acquirers will hold 52% of the company, leading to a change in control and promoter classification.

  • · Offer price is ₹5 per share, equal to the face value of the equity shares.
  • · The open offer is mandatory under Regulations 3(1) and 4 of the SEBI (SAST) Regulations, triggered by the preferential allotment and change in control.
  • · Acquirer-1 (Mahesh Odedra) will also subscribe to 60,00,000 convertible warrants, each convertible into one equity share after 6 months but within 18 months from allotment.
  • · The Acquirers have no prior relationship or interest in the Target Company before this transaction.
  • · The Acquirers have no plans to delist the Target Company, nor to dispose of significant assets outside the ordinary course for two years post offer closure.
  • · The minimum public shareholding will remain above 25% even after full acceptance; if it falls below, the Acquirers will comply with MPS restoration rules.
  • · The Acquirers confirmed they are not willful defaulters, nor barred by SEBI, nor fugitive economic offenders.
Fine Organic Industries Limited Regulatory Action mixed materiality 6/10

21-05-2026

Fine Organic Industries Limited published its standalone and consolidated audited financial results for the quarter and financial year ended March 31, 2026, in newspapers on May 21, 2026. For the full year, standalone total income from operations increased 5.3% to ₹238,993.56 Lakh, while net profit after tax rose 3.0% to ₹34,637.57 Lakh. However, on a consolidated basis, total income from operations grew only 2.5% to ₹248,247.28 Lakh, and net profit after tax increased 4.0% to ₹41,707.40 Lakh, indicating a deceleration in revenue growth compared to the prior year.

  • · The Board of Directors at its meeting on May 19, 2026, recommended a final dividend of ₹11 per equity share.
  • · Standalone total comprehensive income for FY ended March 31, 2026 was ₹33,028.54 Lakh, down from ₹34,684.73 Lakh in the prior year (a decline of 4.8%).
  • · Consolidated total comprehensive income for FY ended March 31, 2026 was ₹40,098.01 Lakh, compared to ₹39,541.38 Lakh in the prior year (an increase of 1.4%).
  • · Standalone net profit for the quarter ended March 31, 2026 was ₹9,006.42 Lakh, up 1.7% from ₹8,853.78 Lakh in the same quarter last year.
  • · Consolidated net profit for the quarter ended March 31, 2026 was ₹11,748.88 Lakh, up 21.0% from ₹9,711.64 Lakh in the same quarter last year.
  • · The results were reviewed by the Audit Committee and approved by the Board on May 19, 2026.
ICICI Prudential Life Insurance Company Limited Rumour Verification neutral materiality 3/10

21-05-2026

ICICI Prudential Life Insurance Company Limited issued a clarification on May 21, 2026, regarding a news article suggesting Standard Chartered may exit its bancassurance tie-up with the company and join Bharti Life Insurance. The company stated that the news article is speculative in nature, providing no further details or financial impact.

  • · The clarification was made under Regulation 30(11) of the SEBI Listing Regulations.
  • · The company explicitly labeled the news article as 'speculative in nature'.
  • · No financial figures, business impact, or further commentary were provided in the filing.
Zydus Lifesciences Limited Buyback positive materiality 8/10

21-05-2026

Zydus Lifesciences Limited announced a buyback of up to 95,65,217 equity shares at ₹1,150 per share, aggregating to ₹1,100 Crore, via a tender offer route. The public announcement was published on May 21, 2026, in Financial Express (English), Jansatta (Hindi), and Financial Express (Gujarati).

  • · Buyback is through the tender offer route on a proportionate basis.
  • · Face value of equity shares is ₹1 each.
  • · Compliance with SEBI (Buy-Back of Securities) Regulations, 2018.
  • · Public announcement published in Financial Express (English), Jansatta (Hindi), and Financial Express (Gujarati).
Isgec Heavy Engineering Limited Regulatory Action negative materiality 7/10

21-05-2026

Isgec Heavy Engineering Ltd. received a penalty order from the Office of the Commissioner of Customs (NS-V), Maharashtra, on May 20, 2026, involving a demand of customs duty of ₹2,76,66,845 and an equal penalty of ₹2,76,66,845, totaling ₹5,53,33,690, plus applicable interest. The dispute arises from an HSN classification issue where the company assessed goods under HSN 86012000, but the customs department alleges they should be classified under HSN 87049012. The company plans to file an appeal under the Customs Act, and the financial impact is quantifiable to the amounts demanded.

  • · The penalty and duty demand each amount to ₹2,76,66,845, totaling ₹5,53,33,690 plus applicable interest.
  • · The alleged violation is an HSN classification error: company used HSN 86012000, customs alleges HSN 87049012.
  • · The company intends to file an appeal under the Customs Act against the order.
  • · The order was received on May 20, 2026, at 15:51 HRS.
ITC Limited Result mixed materiality 8/10

21-05-2026

ITC Limited reported a 9.9% YoY increase in standalone revenue from operations to ₹81,640.11 Cr for FY26, while profit from continuing operations rose marginally by 1.0% to ₹20,286.42 Cr. However, the FMCG-Others segment showed strong growth with EBITDA of ₹2,411.94 Cr, while the Paperboards, Paper & Packaging segment saw a 12.6% decline in segment results to ₹796.71 Cr. The Board recommended a final dividend of ₹8.00 per share, bringing the total dividend to ₹14.50 per share for FY26.

  • · The Board recommended re-appointment of Mr. Hemant Bhargava as an Independent Director for five years from 20 December 2026.
  • · The amalgamation of wholly owned subsidiaries Sresta Natural Bioproducts Private Limited and Wimco Limited with ITC was approved by NCLT and given effect from appointed dates (1 April 2025 for Wimco, 13 June 2025 for Sresta).
  • · Excise duty increased sharply due to GST Compensation Cess expiry and government duty hike on cigarettes from 1 February 2026, impacting comparability of revenue and excise figures.
  • · Exceptional items for FY26 include a one-time past service cost of ₹271.95 Cr due to New Labour Codes and an insurance claim receipt of ₹88.08 Cr.
  • · Total dividend for FY26 is ₹14.50 per share (interim ₹6.50 + final ₹8.00), up from ₹14.35 per share in FY25.
  • · Record date for final dividend is 27 May 2026; payment between 24-29 July 2026 if declared at AGM on 23 July 2026.
Akshar Spintex Limited Regulatory Action negative materiality 5/10

21-05-2026

Akshar Spintex Limited voluntarily paid a penalty of ₹5,15,660 (including GST) to BSE Limited for non-compliance with SEBI LODR regulations. The violations included failure to appoint a qualified Company Secretary as compliance officer for 17 days (Regulation 6(1)) and having less than six directors on the board for 84 days (Regulation 17(1)). The payment was made on May 13, 2026, despite no formal instruction from BSE, reflecting a governance practice.

  • · The penalty was voluntarily paid despite no formal instruction from BSE Limited.
  • · The violations occurred in two separate periods: Sep 30, 2025 to Oct 18, 2025 (Regulation 6(1)) and Nov 25, 2025 to Feb 18, 2026 (Regulation 17(1)).
  • · The total penalty amount of ₹5,15,660 includes GST at 18% on daily fines of ₹1,000 and ₹5,000 respectively.
ITC Limited Corp Action neutral materiality 6/10

21-05-2026

ITC Limited's Board of Directors approved audited financial results for Q4 and full year ended March 31, 2026, with an unmodified audit opinion. The Board recommended a final dividend of ₹8/- per share, bringing the total dividend for FY2026 to ₹14.50 per share, and fixed a record date of May 27, 2026. The 115th Annual General Meeting is scheduled for July 23, 2026, and the re-appointment of Mr. Hemant Bhargava as Independent Director was recommended.

  • · The audit opinion from S R B C & CO LLP is unmodified.
  • · Record date for final dividend entitlement is May 27, 2026.
  • · Final dividend payment period (if declared) is July 24-29, 2026.
  • · Mr. Hemant Bhargava's re-appointment as Independent Director is for five years from December 20, 2026.
ITC Limited Corp. Action positive materiality 8/10

21-05-2026

ITC Limited's Board approved audited financial results for Q4 and FY ended March 31, 2026, with unmodified audit opinion. Recommended a final dividend of ₹8 per share, bringing total dividend to ₹14.50 per share for FY26. Also recommended reappointment of Mr. Hemant Bhargava as Independent Director.

  • · Audited financial results for quarter and twelve months ended March 31, 2026 approved.
  • · Auditors issued unmodified opinion on financial results.
  • · Record date for final dividend: May 27, 2026.
  • · 115th Annual General Meeting scheduled for July 23, 2026.
  • · Final dividend payment period: July 24-29, 2026.
  • · Reappointment of Hemant Bhargava as Independent Director for five years from December 20, 2026.
ITC Limited Corp. Action positive materiality 7/10

21-05-2026

ITC Limited's Board approved audited standalone and consolidated financial results for Q4 and FY ended March 31, 2026, with an unmodified audit opinion. The Board recommended a final dividend of ₹8 per share, bringing the total dividend for FY26 to ₹14.50 per share, and set the record date as May 27, 2026. Additionally, the Board recommended the re-appointment of Mr. Hemant Bhargava as an Independent Director for five years from December 20, 2026.

  • · Audited financial results include standalone and consolidated balance sheet, cash flow statement, and segment-wise revenue for the quarter and twelve months ended March 31, 2026.
  • · Statutory auditors issued an unmodified (clean) opinion on the financial results.
  • · The 115th Annual General Meeting is scheduled for Thursday, July 23, 2026.
  • · Final dividend, if declared, will be paid between July 24 and July 29, 2026.
  • · Record date for final dividend entitlement is Wednesday, May 27, 2026.
  • · Mr. Hemant Bhargava's re-appointment as Independent Director is for five years effective December 20, 2026.
SUN COMMUNITIES INC 8-K neutral materiality 8/10

21-05-2026

Sun Communities, Inc. (SUI) has entered into a definitive agreement to sell its UK assets (Park Holidays) to Aermont Capital for an enterprise value of £768M (~$1.03B) in an all-cash transaction expected to close in H2 2026. Post-transaction, North American MH and RV NOI is expected to represent ~95% of total NOI, reinforcing the company's focus on its core North American platform and improving financial flexibility. The sale is subject to UK FCA approval and customary closing conditions, and the company faces execution risks including potential delays or failure to close.

  • · The sale is structured as an all-cash transaction with locked box adjustments including cash profits up to closing.
  • · Advisors: Lazard Frères & Co. LLC (financial), Jones Day and Taft Stettinius & Hollister LLP (legal) to Sun; Rothschild & Co (financial) and Macfarlanes (legal) to Aermont.
  • · Regulatory approval required from the UK Financial Conduct Authority.
  • · The company aims to return capital to shareholders as part of its capital allocation strategy.
  • · As of March 31, 2026, Sun owned/operated 515 properties with ~179,300 developed sites across the US, Canada, and UK.
BARNWELL INDUSTRIES INC 10-Q mixed materiality 7/10

21-05-2026

Barnwell Industries reported a net loss attributable to the company of $1.15M for Q2 FY2026 (three months ended March 31, 2026), narrowing from a $1.207M loss in the prior-year quarter. Revenue fell 29% to $2.535M, driven by a $1.06M decline in oil and natural gas sales. However, operating costs decreased 19% to $3.983M, and the company recorded a $338,000 equity in income of affiliates, partially offsetting the revenue drop. For the six-month period, the net loss attributable to Barnwell improved to $2.576M from $3.124M a year ago, though cash used in operations increased to $2.422M from $854M.

  • · The company issued 926,403 shares of common stock, net of costs, during the six months ended March 31, 2026, raising $3.365M.
  • · Cash used in operating activities from continuing operations increased to $2.422M in H1 FY2026 from $0.854M in H1 FY2025, a 184% increase.
  • · Capital expenditures for oil and natural gas dropped sharply to $0.25M in H1 FY2026 from $2.641M in H1 FY2025.
  • · The company recorded a $338,000 equity in income of affiliates in Q2 FY2026, compared to $0 in the prior-year quarter.
  • · Accumulated deficit widened to $9.084M at March 31, 2026 from $6.508M at September 30, 2025.
  • · Total liabilities decreased to $13.388M from $13.790M over the same period.
  • · The company had no discontinued operations in FY2026; the prior-year period included a contract drilling segment that was sold.
WhiteHawk Income Corp S-1/A positive materiality 8/10

21-05-2026

PHX Minerals Inc. reported a significant turnaround in Q1 2025, with net income of $4.38M compared to a net loss of $0.18M in Q1 2024, driven by a 47% increase in total natural gas, oil, and NGL sales to $10.43M. However, the company's effective tax rate swung from a 30% benefit to a 23% provision due to higher income, and oil revenue growth was modest at 5.5% YoY, while natural gas revenue surged 86.5%.

  • · The company has a $100M credit facility with a $50M borrowing base, maturing September 1, 2028, with $19.75M drawn and $30.25M available as of March 31, 2025.
  • · The effective interest rate on the credit facility was 7.54% at March 31, 2025.
  • · The company recorded a change in estimate for new wells of $204,141 in Q1 2025 related to prior periods.
  • · Basic EPS improved from -$0.01 in Q1 2024 to $0.12 in Q1 2025.
  • · The company excluded 849,439 restricted shares from diluted EPS in Q1 2025 as they were antidilutive.
  • · The valuation allowance for deferred tax assets remained unchanged at $9,056 from December 31, 2024.
GNMA & US Government Target Maturity Fund for Puerto Rico Residents, Inc. 425 neutral materiality 7/10

21-05-2026

Multiple Puerto Rico closed-end funds are evaluating a strategic shift to an open-end fund structure via mergers, aiming to provide shareholders daily liquidity at NAV. The Board of each fund is conducting a thorough analysis of such mergers, which would require shareholder approval and SEC filings. However, the outcome remains uncertain—if shareholder approval is not obtained, the Board will explore other strategic alternatives to enhance liquidity.

  • · The announement was made on May 20, 2026, from San Juan, Puerto Rico.
  • · Each Fund is a Puerto Rico unlisted closed-end fund registered under the Investment Company Act of 1940.
  • · The evaluation is being conducted by the Board of Directors of each Fund.
  • · A merger would require a final analysis by the Board covering portfolio composition, liquidity, regulatory requirements, tax implications, regulatory approvals, and long-term viability of the surviving open-end fund.
  • · If a merger is approved, the surviving open-end fund would file an SEC registration statement on Form N-14 including a proxy statement/prospectus.
  • · If shareholder approval is not obtained, the Board intends to examine other strategic alternatives to provide enhanced liquidity at or as close to NAV as possible.
  • · Contact information: Patricia Duque, telephone (787) 522-6776.
US Mortgage-Backed & Income Fund for Puerto Rico Residents, Inc. 425 neutral materiality 6/10

21-05-2026

Fourteen Puerto Rico closed-end funds announced a strategic review to pursue mergers with open-end funds to provide better liquidity and operational efficiencies. The boards are evaluating mergers that would allow daily redemptions at NAV, subject to shareholder approval and regulatory filings. If mergers are not approved, the boards will explore other alternatives to enhance liquidity.

  • · The funds are unlisted closed-end funds registered under the Investment Company Act of 1940.
  • · A merger would require shareholder approval and a registration statement on Form N-14.
  • · If a merger is not approved, the board will examine other strategic alternatives to provide liquidity at or close to NAV.
  • · The announcement was made on May 20, 2026, from San Juan, Puerto Rico.
Tax Free Fund II for Puerto Rico Residents, Inc. 425 neutral materiality 6/10

21-05-2026

Tax Free Fund II for Puerto Rico Residents, Inc. and 13 other Puerto Rico closed-end funds announced a strategic review to pursue mergers with open-end funds to provide better liquidity, value, and operational efficiencies. The Boards are evaluating mergers, which would require shareholder approval and regulatory filings. If mergers are not approved, the Boards will consider other alternatives to enhance liquidity.

  • · The Funds are Puerto Rico unlisted closed-end funds registered under the Investment Company Act of 1940.
  • · A merger with an open-end fund would allow shareholders to redeem shares at NAV daily.
  • · The merger process requires Board approval, shareholder approval, and SEC registration.
  • · If shareholder approval is not obtained, the Board will examine other strategic alternatives.
  • · Contact: Patricia Duque at (787) 522-6776.
Ivanhoe Electric Inc. 8-K neutral materiality 3/10

21-05-2026

Ivanhoe Electric Inc. disclosed that its majority-owned subsidiary Cordoba Minerals Corp. entered into a consulting agreement with Quentin Markin as interim CEO, effective May 20, 2026. Mr. Markin will receive a monthly fee of $7,500 plus expense reimbursement. The agreement terminates upon appointment of a new CEO or by notice. Mr. Markin continues as EVP of Business Development and Strategy Execution at Ivanhoe Electric and as a Cordoba Minerals director.

  • · The consulting agreement was entered into on May 20, 2026, retroactively covering services since Mr. Markin's appointment as interim CEO on March 6, 2026.
  • · The agreement can be terminated for cause by Cordoba Minerals or without cause by either party with one month's written notice.
  • · Mr. Markin also serves as a director of Cordoba Minerals.
Tax Free Target Maturity Fund for Puerto Rico Residents, Inc. 425 neutral materiality 6/10

21-05-2026

Multiple Puerto Rico closed-end funds announced a strategic review to pursue mergers with open-end funds to provide better liquidity and operational efficiencies for shareholders. The Boards are evaluating mergers that would allow daily redemptions at NAV, though any merger requires final Board approval, regulatory clearances, and shareholder approval. If shareholder approval is not obtained, the Boards will examine other strategic alternatives to enhance liquidity.

  • · The announcement is made under Rule 425 and involves 14 separate closed-end funds.
  • · The funds are registered under the Investment Company Act of 1940 and are unlisted closed-end funds.
  • · If a merger proceeds, the surviving open-end fund will file a registration statement on Form N-14 with the SEC.
  • · Shareholder approval is required for any merger to proceed.
  • · If shareholder approval is not obtained, the Board will examine other strategic alternatives to provide liquidity at or as close as possible to NAV.
  • · The announcement includes forward-looking statements regarding risks such as market declines, economic downturns, and regulatory changes.
Tax-Free Fixed Income Fund for Puerto Rico Residents, Inc. 425 neutral materiality 6/10

21-05-2026

The Tax-Free Fixed Income Fund for Puerto Rico Residents, Inc. and 13 other Puerto Rico closed-end funds announced a strategic review to pursue a merger with an open-end fund structure, aiming to provide daily liquidity at net asset value for shareholders. The boards are evaluating regulatory, tax, and portfolio implications, and any merger would require shareholder approval. If shareholder approval is not obtained, the boards will explore other strategic alternatives to enhance liquidity.

  • · The funds are unlisted closed-end funds registered under the Investment Company Act of 1940.
  • · A merger with an open-end fund would require final board analysis, regulatory approvals, and shareholder approval.
  • · If a merger is not approved, the board intends to examine other strategic alternatives to provide enhanced liquidity at or close to net asset value.
  • · The surviving open-end fund would file a registration statement on Form N-14 with the SEC, including a proxy statement/prospectus.
  • · Investors can obtain free copies of related documents on the SEC's website at www.sec.gov.
Tax-Free Fixed Income Fund VI for Puerto Rico Residents, Inc. 425 neutral materiality 6/10

21-05-2026

The Funds, a group of 14 Puerto Rico unlisted closed-end funds, announced a strategic review to pursue mergers with open-end funds to provide daily liquidity and operational efficiencies for shareholders. The Board of each Fund is evaluating the mergers, which would require shareholder approval, regulatory clearance, and final Board analysis. If shareholder approval is not obtained for a merger, the respective Board will examine other alternatives to enhance liquidity at or close to net asset value.

  • · The merger evaluation is in an early stage — no registration statement has been filed yet; a surviving open-end fund would file Form N-14 subsequently.
  • · If a merger is approved, shareholders of each target closed-end Fund would receive shares of the surviving open-end fund.
  • · The announcement covers 14 separate Funds, each with its own Board conducting the evaluation.
  • · The Funds currently have no direct path to liquidity for shareholders at NAV due to the closed-end structure.
  • · Contact person: Patricia Duque at (787) 522-6776 for further information.
Tax-Free Fixed Income Fund V for Puerto Rico Residents, Inc. 425 neutral materiality 8/10

21-05-2026

Tax-Free Fixed Income Fund V for Puerto Rico Residents, Inc. and 13 other Puerto Rico closed-end funds announced a strategic review to pursue mergers with open-end funds to provide daily liquidity and operational efficiencies. The Boards are evaluating mergers subject to final analysis, regulatory approvals, and shareholder votes; if shareholder approval is not obtained, the Boards will examine other strategic alternatives to enhance liquidity at or near net asset value.

  • · The announcement was made on May 20, 2026, from San Juan, Puerto Rico.
  • · Each Fund is a Puerto Rico unlisted closed-end fund registered under the Investment Company Act of 1940.
  • · The merger would require shareholder approval; if not obtained, the Board will examine other strategic alternatives to provide enhanced liquidity at or as close as possible to net asset value.
  • · The surviving open-end fund would file a registration statement on Form N-14 with the SEC, including a proxy statement/prospectus.
  • · Investors can obtain free copies of relevant documents on the SEC's website at www.sec.gov.
Tax-Free Fixed Income Fund III for Puerto Rico Residents, Inc. 425 neutral materiality 8/10

21-05-2026

Tax-Free Fixed Income Fund III for Puerto Rico Residents, Inc., along with 13 other Puerto Rico closed-end funds, announced a strategic review to pursue a merger with an open-end fund, seeking to provide better liquidity, value, and operational efficiencies for shareholders. This structural change would allow daily redemptions at net asset value, a significant improvement over the current closed-end structure. However, the merger is subject to Board approval, regulatory requirements, tax implications, and shareholder approval; if approval is not obtained, the Board will explore other alternatives. The announcement is forward-looking and carries risks including market declines, regulatory changes, and inability to implement the strategy.

  • · The merger would require a surviving open-end fund to file a registration statement on Form N-14 with the SEC, including a proxy statement/prospectus.
  • · If shareholder approval for a merger is not obtained, the Board intends to examine other strategic alternatives to provide enhanced liquidity at or close to net asset value.
  • · The Funds are unlisted closed-end funds registered under the Investment Company Act of 1940.
  • · Forward-looking statements caution that risks include market declines, economic downturns, competition, regulatory changes, and inability to retain key employees or implement the investment strategy.
BARNWELL INDUSTRIES INC DEF 14A neutral materiality 5/10

21-05-2026

Barnwell Industries, Inc. filed a DEF 14A proxy statement for its 2026 Annual Meeting of Stockholders, scheduled for a date to be determined, with a record date of May 4, 2026, and 14,338,575 shares of common stock issued and outstanding. The meeting will include six proposals: election of directors, approval of amendments to the 2018 Equity Incentive Plan, ratification of equity awards granted in excess of individual share limits, an advisory vote on executive compensation, an advisory vote on the frequency of the say-on-pay vote, and ratification of Weaver and Tidwell, L.L.P. as the independent auditor for fiscal year 2026. The proxy statement provides detailed executive compensation information for the fiscal year ended September 30, 2025, but the filing does not include specific financial performance metrics or period-over-period comparisons, limiting the ability to assess company performance trends.

  • · The proxy materials are being distributed on or about May 20, 2026.
  • · Stockholders of record as of May 4, 2026 are entitled to vote.
  • · A quorum requires a majority of issued and outstanding shares.
  • · Proposal 1 (Election of Directors) requires a plurality vote; abstentions and broker non-votes have no effect.
  • · Proposal 2 (Amendments to 2018 Plan) requires a majority of shares present; abstentions count as votes against.
  • · Proposal 3 (Ratification of Excess Awards) requires a majority of shares present; abstentions count as votes against.
  • · Proposal 4 (Advisory Say-on-Pay) is non-binding and requires a majority of shares present; broker non-votes have no effect.
  • · Proposal 5 (Frequency of Say-on-Pay) is advisory and non-binding.
  • · Proposal 6 (Ratification of Auditor) is a routine matter where brokers may vote without instructions.
  • · No cumulative voting rights exist for common stockholders.
Tax-Free High Grade Portfolio Bond Fund II for Puerto Rico Residents, Inc. 425 neutral materiality 6/10

21-05-2026

Fifteen Puerto Rico closed-end funds announced a strategic review to pursue mergers with open-end funds to provide better liquidity, value, and operational efficiencies for shareholders. The Boards are evaluating mergers that would allow daily redemptions at net asset value, but any merger is subject to final Board analysis, regulatory approvals, and shareholder approval. If shareholder approval is not obtained, the Boards will examine other strategic alternatives to enhance liquidity.

  • · The announcement was made on May 20, 2026, from San Juan, Puerto Rico.
  • · Each Fund is a Puerto Rico unlisted closed-end fund registered under the Investment Company Act of 1940.
  • · The surviving open-end fund would file a registration statement on Form N-14 with the SEC, including a proxy statement/prospectus.
  • · Investors can obtain free copies of relevant documents on the SEC's website at www.sec.gov.
  • · The statement is not an offer to buy or sell any securities or a solicitation of any vote or approval.
Tax-Free High Grade Portfolio Target Maturity Fund for Puerto Rico Residents, Inc. 425 neutral materiality 6/10

21-05-2026

Multiple Puerto Rico closed-end funds announced a strategic review to pursue mergers with open-end funds to provide better liquidity and shareholder value. The Boards are evaluating mergers that would allow daily redemptions at net asset value, subject to final analysis, regulatory approvals, and shareholder votes. If shareholder approval is not obtained, the Boards will examine other alternatives to enhance liquidity.

  • · The announcement is preliminary; no definitive merger agreements have been reached.
  • · Any merger would require shareholder approval and SEC registration on Form N-14.
  • · If a merger is not approved, the Board will explore other strategic alternatives to provide liquidity at or near net asset value.
  • · The funds are unlisted closed-end funds registered under the Investment Company Act of 1940.
  • · The surviving open-end fund would issue shares to closed-end fund shareholders upon merger approval.
Puerto Rico Residents Tax-Free Fund III, Inc. 425 neutral materiality 6/10

21-05-2026

Puerto Rico Residents Tax-Free Fund III, Inc. and 13 other Puerto Rico closed-end funds announced a strategic review to pursue mergers with open-end funds to provide better liquidity, value, and operational efficiencies for shareholders. The Boards are evaluating mergers that would allow daily redemptions at net asset value, but any merger requires final Board analysis, regulatory approvals, and shareholder approval. If shareholder approval is not obtained, the Boards will examine other strategic alternatives to enhance liquidity.

  • · The funds are unlisted closed-end funds registered under the Investment Company Act of 1940.
  • · A merger would require the surviving open-end fund to file a registration statement on Form N-14 with the SEC, including a proxy statement/prospectus.
  • · Shareholder approval is required for any merger to proceed.
  • · If a merger is not approved, the Board will examine other strategic alternatives to provide liquidity at or close to net asset value.
  • · The announcement was made on May 20, 2026, from San Juan, Puerto Rico.
Puerto Rico Residents Tax-Free Fund V, Inc. 425 neutral materiality 5/10

21-05-2026

The Board of Directors of 14 Puerto Rico closed-end funds, including Puerto Rico Residents Tax-Free Fund V, Inc., is evaluating a merger with an open-end fund to provide shareholders with daily liquidity at net asset value (NAV). Any merger would require shareholder approval, regulatory filings, and Board finalization; if a merger is not approved, the Board will examine other alternatives to enhance liquidity. The funds are currently pursuing this alternative to address the existing closed-end structure's lack of a direct redemption path.

  • · The Board is conducting a thorough evaluation of a merger with an open-end fund, which would provide a direct path to liquidity via daily redemptions at NAV, unlike the current closed-end structure.
  • · If a Fund cannot obtain required shareholder approval for a merger, its Board intends to examine other strategic alternatives to provide enhanced liquidity at or as close to NAV as possible.
  • · The surviving open-end fund would file a registration statement on Form N-14 (including a proxy statement/prospectus) with the SEC; no securities offering will be made except by means of a prospectus meeting Section 10 of the Securities Act of 1933.
  • · Investors are urged to read the joint proxy statement/prospectus and other documents when available, free of charge on the SEC’s website at www.sec.gov.
Tax-Free High Grade Portfolio Bond Fund for Puerto Rico Residents, Inc. 425 neutral materiality 6/10

21-05-2026

A group of 14 Puerto Rico closed-end funds announced a strategic review to pursue mergers with open-end funds to provide better liquidity and operational efficiencies for shareholders. The boards are evaluating this alternative, which would allow daily redemptions at NAV, but any merger requires shareholder approval and regulatory filings. If shareholder approval is not obtained, the boards will explore other strategic alternatives to enhance liquidity.

  • · The funds are registered under the Investment Company Act of 1940 as Puerto Rico unlisted closed-end funds.
  • · A merger would require shareholder approval, regulatory approvals, and a registration statement on Form N-14.
  • · If shareholder approval is not obtained, the boards will examine other strategic alternatives to provide liquidity at or close to NAV.
  • · The announcement was made on May 20, 2026, from San Juan, Puerto Rico.
Puerto Rico Residents Tax-Free Fund II, Inc. 425 neutral materiality 6/10

21-05-2026

Puerto Rico Residents Tax-Free Fund II, Inc. and 14 other Puerto Rico closed-end funds announced a strategic review to pursue mergers with open-end funds to provide better liquidity, value, and operational efficiencies for shareholders. The Boards are evaluating mergers that would allow daily redemptions at NAV, subject to final analysis, regulatory approvals, and shareholder votes. If shareholder approval is not obtained, the Boards will examine other strategic alternatives to enhance liquidity.

  • · The announcement was made on May 20, 2026, from San Juan, Puerto Rico.
  • · Each Fund is a Puerto Rico unlisted closed-end fund registered under the Investment Company Act of 1940.
  • · A merger would require final Board analysis including portfolio composition, liquidity, regulatory requirements, tax implications, and long-term viability of the surviving open-end fund.
  • · After Board approval, the surviving open-end fund would file a registration statement on Form N-14 with the SEC, which would include a proxy statement for shareholder vote.
  • · If a merger is not approved, the Board intends to examine other strategic alternatives to provide liquidity at or as close as possible to NAV.
  • · No specific timeline or financial terms were disclosed.
Puerto Rico Residents Bond Fund I 425 neutral materiality 6/10

21-05-2026

Puerto Rico Residents Bond Fund I and 14 other Puerto Rico closed-end funds announced a strategic review to pursue mergers with open-end funds to provide better liquidity, value, and operational efficiencies for shareholders. The Boards are evaluating mergers that would allow daily redemptions at net asset value, subject to final analysis, regulatory approvals, and shareholder votes. If shareholder approval is not obtained, the Boards will examine other strategic alternatives to enhance liquidity.

  • · The announcement was made on May 20, 2026, from San Juan, Puerto Rico.
  • · Each Fund is a Puerto Rico unlisted closed-end fund registered under the Investment Company Act of 1940.
  • · The merger would require shareholder approval and a registration statement (Form N-14) to be filed with the SEC.
  • · If a merger is not approved, the Board intends to examine other strategic alternatives to provide liquidity at or as close as possible to net asset value.
  • · Contact for further information: Patricia Duque, telephone (787) 522-6776.
DALRADA FINANCIAL CORP 10-Q mixed materiality 9/10

21-05-2026

DALRADA TECHNOLOGY GROUP (DHTI) reported a net loss of $4.3M for the quarter ended March 31, 2026, roughly flat vs. a $4.2M loss in the same quarter last year, while total revenue declined 44% YoY to $2.6M. For the nine-month period, revenue fell 28% YoY to $9.9M, and the net loss improved 17% to $14.8M. The company continues to operate with negative stockholders' equity of -$20.9M and total current liabilities of $29.9M far exceed current assets of $8.0M, signaling acute liquidity risk.

  • · Cash and cash equivalents fell 52% from $172.8K at June 30, 2025 to $82.6K at March 31, 2026.
  • · Total liabilities increased 54% from $25.0M to $38.5M, driven by a surge in accounts payable and accrued liabilities – related parties (from $3.4M to $10.5M) and notes payable, current portion (from $3.9M to $9.1M).
  • · Stockholders' deficit worsened from -$6.7M to -$20.8M, more than tripling.
  • · Net cash used in operating activities for the nine months was $6.1M, roughly flat compared to $6.1M in the prior year period.
  • · Interest expense for the nine months increased 9.8% to $2.6M from $2.4M, while interest income dropped 91.2% to $5.1K.
  • · The company issued 14,206 shares of Series I preferred stock during Q1 FY2026 upon conversion of related party notes.
  • · Approximately $11.9M of preferred stock to be issued was reclassified to additional paid-in capital during the second quarter.
  • · Loss per share improved from -$0.19 to -$0.14 (basic and diluted) for the nine-month period.

Get daily alerts with 11 investment signals, 10 risk alerts, 9 opportunities and full AI analysis of all 50 filings

$30/mo after a 14-day free trial — no credit card required. See pricing or explore intelligence streams.

More from: Global High-Priority Regulatory Events

🇺🇸 More from United States

View all →